Characteristics of Persons Screened for Lung Cancer in the United States
暂无分享,去创建一个
E. Kazerooni | P. Mazzone | N. Tanner | G. Silvestri | S. Fedewa | M. Gould | M. P. Rivera | V. P. Doria-Rose | J. Burleson | L. Rosenthal | Lenka Goldman | M. Simanowith | Robert A. Smith | M. Rivera | Michael Simanowith | Lauren S. Rosenthal
[1] Alireza Heidari,et al. Screening for Lung Cancer with Low Dose Computed Tomography (LDCT) , 2021, Journal of Chemistry and Applications.
[2] M. Cabana,et al. Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement. , 2021, JAMA.
[3] C. Berg,et al. Using Prediction-Models to Reduce Persistent Racial/Ethnic Disparities in Draft 2020 USPSTF Lung-Cancer Screening Guidelines. , 2021, Journal of the National Cancer Institute.
[4] R. Volk,et al. Patient Adherence to Screening for Lung Cancer in the US , 2020, JAMA network open.
[5] N. Tanner,et al. Screening Adherence in the Veterans Administration Lung Cancer Screening Demonstration Project. , 2020, Chest.
[6] Harry J de Koning,et al. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. , 2020, The New England journal of medicine.
[7] H. Katki,et al. Basing eligibility for lung cancer screening on individualized risk calculators should save more lives, but life-expectancy matters. , 2019, Journal of the National Cancer Institute.
[8] L. Tanoue,et al. Incorporating Coexisting Chronic Illness into Decisions about Patient Selection for Lung Cancer Screening. An Official American Thoracic Society Research Statement , 2018, American journal of respiratory and critical care medicine.
[9] P. Mazzone,et al. Screening for Lung Cancer: CHEST Guideline and Expert Panel Report , 2018, Chest.
[10] N. Tanner,et al. Assessing the Generalizability of the National Lung Screening Trial: Comparison of Patients with Stage 1 Disease , 2017, American journal of respiratory and critical care medicine.
[11] Summer S. Han,et al. Evaluating the impact of varied compliance to lung cancer screening recommendations using a microsimulation model , 2017, Cancer Causes & Control.
[12] Arash Naeim,et al. Cost-effectiveness of CT screening in the National Lung Screening Trial. , 2014, The New England journal of medicine.
[13] V. Moyer. Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2014, Annals of Internal Medicine.
[14] C. Berg,et al. Targeting of low-dose CT screening according to the risk of lung-cancer death. , 2013, The New England journal of medicine.
[15] V. Vaidya,et al. Gender differences in utilization of preventive care services in the United States. , 2012, Journal of women's health.
[16] C. Gatsonis,et al. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .
[17] Howard K Koh,et al. Promoting prevention through the Affordable Care Act. , 2010, The New England journal of medicine.
[18] A Donner,et al. Construction of confidence limits about effect measures: A general approach , 2008, Statistics in medicine.
[19] M. Roizen. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .